Hims & Hers Health (HIMS) EBIT (QoQ) (2019 - 2026)
Hims & Hers Health (HIMS) EBIT (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.91 Bn | 18.02 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | Hims & Hers Health | 7.87 Bn | 7.03 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.09% |
| Mar 31, 2026 | -952.63% |
| Dec 31, 2025 | -22.20% |
| Sep 30, 2025 | -55.82% |
| Jun 30, 2025 | -53.84% |
| Mar 31, 2025 | 211.34% |
| Dec 31, 2024 | -16.89% |
| Sep 30, 2024 | 102.85% |
| Jun 30, 2024 | 11.38% |
| Mar 31, 2024 | 2,575.75% |
| Dec 31, 2023 | 95.32% |
| Sep 30, 2023 | 7.38% |
| Jun 30, 2023 | 18.00% |
| Mar 31, 2023 | 2.95% |
| Dec 31, 2022 | 41.93% |
| Sep 30, 2022 | 1.03% |
| Jun 30, 2022 | -19.33% |
| Mar 31, 2022 | 21.54% |
| Dec 31, 2021 | 22.04% |
| Sep 30, 2021 | -58.91% |